Boston Scientifics Pivotal Trial Shows Over 93 Success Rate for Device RLAY Q1 2026 Earnings ClinicalStage Biotech Misses EPS Estimates as Pipeline Advances BrownForman Price Target Trimmed by Analyst Ahead of Q4 Release